Slingsby Brian Taylor insider trades
Slingsby Brian Taylor has filed 7 Form 4s with the SEC that we hold, all for Mineralys Therapeutics, Inc. (MLYS), as Director. Across all of them we count 2 purchases worth $7.5M and 2 sales worth $10.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($3.0M). The largest single trade was a sale of 550,000 shares of Mineralys Therapeutics, Inc. worth $7.2M, dated 2024-07-24. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2023-02-16 and the latest 2026-09-24.
Mineralys Therapeutics, Inc. (MLYS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-02-14 | P, purchase reported on Form 4 | 250,000 | $4.0M | 2023-02-16 |
| 2024-07-24 | S, sale reported on Form 4 | 550,000 | $7.2M | 2024-07-26 |
| 2025-03-13 | P, purchase reported on Form 4 | 259,259 | $3.5M | 2025-04-25 |
| 2026-09-22 | S, sale reported on Form 4 | 104,320 | $3.0M | 2026-09-24 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1963901) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms